From UPI:
Something as simple as aspirin may help lower the risk of death in hospital patients who are fighting a tough case of COVID-19, a new study found.
George Washington University researchers analyzed data on more than 112,000 patients hospitalized with moderate COVID-19 at 64 health systems in the United States from Jan. 1, 2020, through Sept. 10, 2021.
Compared to patients who weren't given aspirin, those who received aspirin within the first day of hospitalization had a 1.6% lower risk of death, and also had a lower risk of blood clots.
[.]
"This is our third study and the culmination of 15 months of work looking at aspirin use in hospitalized COVID-19 patients," said lead researcher Dr. Jonathan Chow, an associate professor at the university's School of Medicine.
"We continue to find that aspirin use is associated with improved outcomes and lower rates of death in hospitalized patients," Chow said in a university news release. "What's more, it's low-cost and readily available, which is important in parts of the world where more expensive therapeutics might not be as accessible."
Aspirin? Is that even approved by the FDA?
No comments:
Post a Comment